Our live Investing Matters Podcast Special which took place at the Master Investor Show discussing 'How undervalued is the UK stock market?', has just been released. Listen here.
If those words were written in December then it just seems odd that 12 months resources no longer satisfy the likely run rates on expenditure? Things must have changed quite alot in the last couple of months?
Anyway orphan status seems to be the key now and that doesn't cost anything but time that we should already have budget for (3 months from now is early June). I'm just confused as to why they didn't wait until we knew the outcome of that before diluting shareholders holdings even more.
As for the AGM, there doesn't seem much point in taking time out of a busy schedule to ask questions if things are so fluid. Probably better to wait and see what happens with orphan progress or maybe see what comes out of the next Telegram session.
"..prudent expectations of income from out-licensing rights to its programmes OR a fundraising"
Well there's the fundraiser....so I guess they're not expecting much income from outlicensing?
We'll see 3 months after they get around to applying for orphan status
Yes Chab, I also seem to vaguely recall reading words about having enough money to see us through for a while, something along the lines of:
"However, it is the Directors' reasonable expectation that the Group has adequate resources to continue to operate as a going concern for at least twelve months from the date of the approval of the accounts. In forming this assessment, the Directors have prepared cashflow forecasts covering the period ending 31 December 2024"
Ah well, the more the merrier, eh?
As for yesterday's question from Older: "Why not a subscription for existing shareholders?".
I think the question might have been a little naive. Do you not think long term shareholders can be a bit high maintenance? They tend to stick around, expect results and remember all the stuff that was promised and never delivered. Why go cap in hand to them if you can get money from more ethereal sources that appear to be able to profit from a quick exit without the need to get bogged down filing unnecessary notification paperwork? That sounds like a win - win to me.
PS. I also heard someone mention in recent posts that the board had stopped taking remuneration until the company was in a position to afford it. I'm not sure it's accurate to say it was entire board. However, it's a very noble gesture from those who have taken the hit:
"In addition, the non-executive directors have elected not to take payment of their salaries until such time as the business holds sufficient funds to enable them to do so."
Thanks again to Older for sharing what he heard at the recent Telegram trader huddle. One thing I think that did stand out from that was the importance of gaining orphan status if we want any kind of a meaningful deal with big pharma. That means we should all know whether or not this really has legs in about 3 months...and if we don't get it, well, maybe we can discharge the upkeep of any future costs of the patent estate in some other way.
Thankyou for relaying what you heard Older.
I still struggle with some of the points though, maybe I've just misunderstood but here's my twopenneth :
1. If they can apply for orphan status at any point, why have they not already done so already? I thought it might be because they needed formal approval of the EU patent first but your statement seems to suggest it can be done anytime and it's free. Why did he delay?
2. Re-purposing is suddenly a bad thing? Nuformix have been touting it as the best thing since sliced bread since I can remember. Isn't that how they sold it to us in the first place? Safer, shorter timescales etc... Surely they were aware that ownership could be an issue. Isn't that why they chose Tranilast? How can partners be concerned about ownership issues if Tranilast is well beyond its patent protection? It wasn't a problem for Oxilio with Apprepitant.
3. "Dan seemed to think that recent selling was final leftovers from Lanstead's last placing." I don't swallow that at all. 35m shares is around 5%. You would still have to notify and Lanstead were pretty regular with that when they were offloading during the agreement period. Why would they not issue the last TR1. What about the mysterious price rise just before the sell off?
I know Soup is held in high regard by many on here but I'm not sure that repeating his now standard 'out of office' response to anything that NFTs posts makes much sense. I mean if you look at the 3 year chart, we're just not doing that great ourselves!
Probably best to leave that sort of stuff to his more banal, unoriginal trader followers (like Whimax) 🤣
"Yeah, cos obviously the only way to hold discussions these days is face to face, and for 24hrs a day until a deal is signed"
Pretty reckless to partake in dangerous sports during such a crucial period of discussion though, don't you think Whimax? You'd be mighty concerned if he'd wound up in a coma a result, wouldn't you?
No, of course you wouldn't, because your just a trader who's not really invested 🙄
I'm guessing NFT's cryptic post is reference to rumours circulating on other boards regarding a certain skiing accident?
If they are true then it would seem irresponsible to take a break from critical discussions to put yourself at risk of injury on the slopes. Might have been wiser to relax on a beach somewhere.
Then again, might also be an indication that IF there were any talks ongoing, they are now largely done.
There's nothing left for me to take out.
I've said it before, I have no confidence in Gooding's leadership after he deserted us but I do believe in NXP002. My only hope is that someone will jump in and take it from them before it gets sold off to some minnow as part of deal that offers nothing of value to NFX shareholders.
I can see why you're hopeful, Drago:
"Major licensee technical objections regarding viability of NXP002 as an inhaled therapy are now addressed..."
What a thing to be able to boast. They should be shouting from the rooftops. Absolutely no reason for them to not make solid progress in those talks now! Is there?
That 'declaration' was made back in December. How much more convincing does this 'major licensee' need?
Dunno. Very opportune for that big seller though, wasn't it?
I always thought issuing warrants increased the number of shares in circulation. Doesn't seem to have happened in this case though (if it was indeed anything to do with warrants)
Fair enough, so you attended this presentation and heard Gooding deliver it?
I just hadn't heard about it and wondered why it was not open to everyone? It sounds like he was delivering some pretty relevant information there. As you quoted:
"Major licensee technical objections regarding viability of NXP002 as an inhaled therapy are now addressed..." that's quite a thing. Who is the major licensee?
Exactly when in December did this take place, if you don't mind spoonfeeding me just a little more?